www.nytimes.com1 month agoMedicineMany People Are Eligible for Paxlovid. Who Should Take It?Most adults in the U.S. are eligible for Paxlovid, but confusion and lack of provider experience limit its prescription despite proven benefits. [ more ]
www.nytimes.com3 months agoMedicineA Drug to Slow Alzheimer's Is Finally Available. How Are Patients Faring?The Alzheimer's drug lecanemab offers hope with modest benefits and high risks, as strict criteria determine patient eligibility. [ more ]